Claims
- 1. A method for decontaminating an area in which a hydrate-forming toxic agent has been released, said method comprising:
gathering said toxic agent into a containment vessel; and admixing said toxic agent in said containment vessel with water under temperature and pressure conditions conducive to the formation of gas hydrate of said toxic agent so as to form toxic agent hydrate.
- 2. The method of claim 1, wherein said toxic agent has a molecular size that is less than or equal to about 7 Å.
- 3. The method of claim 2, wherein said toxic agent is selected from the group consisting of chlorine, bromine, and hydrogen cyanide.
- 4. The method of claim 2, wherein said toxic agent forms type sI or type sII hydrate.
- 5. The method of claim 1, wherein said toxic agent has a molecular size that is greater than about 7 Å.
- 6. The method of claim 5, wherein said toxic agent is a nerve agent.
- 7. The method of claim 6, wherein said nerve agent is a non-persistent nerve agent.
- 8. The method of claim 7, wherein said non-persistent nerve agent is selected from the group consisting of Sarin, Soman, Tabun, and Cyclohexyl methylphosonoflouridate.
- 9. The method of claim 6, wherein said nerve agent is a persistent nerve agent.
- 10. The method of claim 9, wherein said nerve agent is VX.
- 11. The method of claim 5, wherein said toxic agent is mustard gas.
- 12. The method of claim 5, wherein said toxic agent forms type sH hydrate.
- 13. The method of claim 12, further comprising admixing a helper or companion agent with said toxic agent and said water in said containment vessel, said helper agent and said toxic agent filling smaller voids and larger voids in said type sH hydrate, respectively.
- 14. The method of claim 13, wherein said helper or companion agent is also a toxic agent.
- 15. The method of claim 13, wherein said helper or companion agent is non-toxic.
- 16. The method of claim 13, wherein said helper or companion agent is selected from the group consisting of carbon dioxide, chlorine, hydrogen sulfide, and methane.
- 17. The method of claim 1, wherein said toxic agent is gaseous or forms a gas under ambient temperature and pressure conditions and wherein gathering said toxic agent into said containment vessel comprises drawing or pumping said toxic agent in its gaseous or liquid form into said containment vessel along with atmospheric air in which said toxic agent has been dispersed.
- 18. The method of claim 1, wherein said admixing comprises spraying water into said containment vessel.
- 19. The method of claim 1, wherein said containment vessel is filled with said water and said admixing comprises bubbling said toxic agent through said water.
- 20. The method of claim 1, further comprising pressurizing said containment vessel.
- 21. The method of claim 1, further comprising cooling said containment vessel.
- 22. The method of claim 1, wherein said containment vessel is modular or detachable, said method further comprising replacing said containment vessel with an empty, replacement containment vessel when said containment vessel has become filled with toxic agent hydrate.
- 23. The method of claim 1, further comprising recycling water that has been introduced into said containment vessel but has not participated in hydrate formation.
- 24. The method of claim 1, further comprising venting cleaned air from said containment vessel.
- 25. Apparatus for decontaminating an area in which a toxic, hydrate-forming agent has been released, said apparatus comprising:
a relatively light-weight, portable containment vessel, said containment vessel being pressurizeable and constructed of waterproof materials; a water spray distribution system disposed within said containment vessel for spraying water into the interior of said containment vessel; and a toxic agent intake system, said toxic agent intake system comprising one or more light-weight, collapsible intake conduits and a pump system configured to draw said toxic agent into said one or more conduits and deliver said toxic agent into said containment vessel.
- 26. The apparatus of claim 25, further comprising a companion gas injection conduit configured to introduce a companion gas into said apparatus to be mixed with said toxic agent.
- 27. The apparatus of claim 25, further comprising means for cooling said containment vessel.
- 28. Integrated air circulation and toxic agent decontamination apparatus, comprising:
air circulation ducting disposed within a building or other area in which people gather; a pressurizeable containment vessel in communication with said air circulation ducting; and a water spray distribution system disposed within said containment vessel for spraying water into the interior of said containment vessel.
- 29. The apparatus of claim 28, further comprising a companion gas injection conduit configured to introduce a companion gas into said apparatus to be mixed with said toxic agent.
- 30. The apparatus of claim 28, further comprising means for cooling said containment vessel.
- 31. A method for decontaminating an area in which a hydrate-forming toxic agent has been released, the molecular size of said agent being of a large size incapable of forming a stable hydrate of sI or sII type, said method comprising:
gathering said toxic agent in a containment vessel; admixing said toxic agent in a containment vessel with water and a hydrate-forming companion agent, the companion agent being of a molecular size capable of forming a stable hydrate of sI or sII type; and controlling temperature and pressure conditions in said vessel so as to cause the water, the toxic agent, and the companion agent to form a stable hydrate containing both the toxic agent and the companion agent.
- 32. The method of claim 31, wherein said toxic agent is a nerve agent.
- 33. The method of claim 32, wherein said nerve agent is a non-persistent nerve agent.
- 34. The method of claim 33, wherein said non-persistent nerve agent is selected from the group consisting of Sarin, Soman, Tabun, and Cyclohexyl methylphosonoflouridate.
- 35. The method of claim 32, wherein said nerve agent is a persistent nerve agent.
- 36. The method of claim 35, wherein said nerve agent is VX.
- 37. The method of claim 31, wherein said toxic agent is gaseous or forms a gas under ambient temperature and pressure conditions and wherein said gathering said toxic agent into said containment vessel comprises drawing said toxic agent into said containment vessel along with atmospheric air in which said toxic agent has been dispersed.
- 38. The method of claim 37, wherein said admixing comprises spraying water into said containment vessel.
- 39. The method of claim 37, wherein said admixing comprising bubbling the atmosphere air in which said toxic agent has been dispersed through a water bath.
- 40. The method of claim 31, further comprising recycling water that has been introduced into said containment vessel but has not participated in hydrate formation.
- 41. The method of claim 31, further comprising venting decontaminated air from said containment vessel.
- 42. The method of claim 31, further comprising deploying portable hydrate-formation decontamination apparatus in the vicinity of said decontamination site, said portable hydrate-formation decontamination apparatus including said containment vessel.
- 43. The method of claim 31, wherein said toxic agent is liquid under ambient temperature and pressure conditions and wherein said gathering comprises by pumping said toxic agent and into said containment vessel.
- 44. The method of claim 31, further comprising constructing said containment vessel on sites in the area in which said toxic agent has been released, said containment vessel being constructed as an enclosure which surrounds and isolates the sites of said toxic agent release.
- 45. The method of claim 44, further comprising pressurizing said enclosure.
- 46. A method for neutralizing a nerve agent, the molecular size of said nerve agent being of a large size incapable of forming a stable hydrate of sI or sII type, said method comprising:
admixing said nerve agent in a containment vessel with water and a hydrate-forming companion agent, the companion agent being of a molecular size capable of forming a stable hydrate or sI or sII type; controlling temperature and pressure conditions in said vessel so as to cause the water, the toxic agent, and the companion agent to form a stable hydrate containing both the toxic agent and the companion agent.
- 47. The method of claim 46, wherein said nerve agent is a non-persistent nerve agent.
- 48. The method of claim 47, wherein said non-persistent nerve agent is selected from the group consisting of Sarin, Soman, Tabun, and Cyclohexyl methylphosonoflouridate.
- 49. The method of claim 46, wherein said nerve agent is a persistent nerve agent.
- 50. The method of claim 49 wherein said nerve agent is VX.
- 51. The method claim 46, wherein said nerve agent has been released and said method further comprises gathering said nerve into said containment vessel.
- 52. The method of claim 51, wherein said toxic agent is gaseous or forms a gas under ambient temperature and pressure conditions and wherein said gathering said toxic agent into said containment vessel comprises drawing said toxic agent into said containment vessel along with atmospheric air in which said toxic agent has been dispersed.
- 53. The method of claim 52, wherein said admixing comprises spraying water into said containment vessel.
- 54. The method of claim 52, wherein said admixing comprising bubbling the atmosphere air in which said toxic agent has been dispersed through a water bath.
- 55. The method of claim 46, further comprising recycling water that has been introduced into said containment vessel but has not participated in hydrate formation.
- 56. The method of claim 46, further comprising venting decontaminated air from said containment vessel.
- 57. The method of claim 46, further comprising deploying portable hydrate-formation decontamination apparatus in the vicinity of said decontamination site, said portable hydrate-formation decontamination apparatus including said containment vessel.
- 58. The method of claim 57, further comprising constructing said containment vessel on sites in the area in which said toxic agent has been released, said containment vessel being constructed as an enclosure which surrounds and isolates the sites of said toxic agent release.
- 59. The method of claim 51, wherein said toxic agent is liquid under ambient temperature and pressure conditions and wherein said gathering comprises by pumping said toxic agent and into said containment vessel.
Parent Case Info
[0001] This Application is based on and claims the benefit of Provisional Patent Application Nos. 60/329,316 filed Oct. 16, 2001, and 60/354,248 filed Feb. 6, 2002, the entire contents of which are hereby incorporated by reference.
Provisional Applications (2)
|
Number |
Date |
Country |
|
60329316 |
Oct 2001 |
US |
|
60354248 |
Feb 2002 |
US |